Assort Health Raises $76M Series B for Voice AI Healthtech Platform
Assort Health has raised a $76 million Series B led by Lightspeed Venture Partners, bringing total funding to $102 million in just the last four months. Felicis, First Round Capital, Chemistry, A*, Liquid2, and Quiet Capital all participated in the round. The startup's Series A in April was co-led by First Round Capital and Chemistry. Earlier backers include seed investor Quiet Capital and pre-seed investor Pioneer Fund.
The company automates healthcare call centers with specialty-specific voice AI agents across fields like orthopedics, cardiology, and immunology. The AI agents triage incoming patient calls by answering frequently asked questions and routing patients to the right person in the clinic.
Assort embeds into electronic health record and practice management software to schedule appointments and resolve patient issues. It accommodates providers' changing schedule preferences and reduces the time patients spend on the phone. The company says customers see return on investment in roughly 30 days.
The rapid fundraising reflects strong demand. Co-founder and co-CEO Jon Wang said the company didn't raise to cover burn but to scale a platform solving a patient access problem others haven't been able to solve. The decision to raise a Series B was driven by demand from both patients and providers, not financial need.
Co-founder and co-CEO Jeff Liu distinguishes Assort's approach from other voice AI solutions in healthcare, emphasizing the company's focus on comprehensive workflow automation and safety measures rather than surface-level implementations.
Assort also automates other parts of the healthcare workflow including care navigation, lab tests, prescription renewals, and physician referrals. The company will use the funds to grow its team and expand its voice AI platform, AssortOS.
As part of the funding deal, Galym Imanbayev, a partner at Lightspeed Venture Partners, will join the board. Paul Ricci, founding CEO of Nuance, will join as a board advisor.
The deal positions Assort in a growing category of healthcare AI startups focused on front office automation. Voice AI for patient engagement has attracted significant venture capital recently as practices look for ways to reduce administrative burden while improving patient access to care.